MedPath

Study to find out the safety and efficacy of Pralidoxime in the management of patients with acute organophosphorous pesticide poisoning

Phase 4
Conditions
Health Condition 1: null- Acute organophosphorous poisoning
Registration Number
CTRI/2014/02/004392
Lead Sponsor
JIPMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

1.Patients with organophosphate poisoning

2.Age > 18yrs

3.Presenting within 12 Hours of ingestion

Exclusion Criteria

1.Patients with mixed compound poisioning

2.Patients with carbamate poisioning

3.Intubated and mechanically ventilated before presentation

4.Received more than 1 dose of pralidoxime before randomization

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath